The combination of dermoscopy and reflectance confocal microscopy increases the diagnostic confidence of amelanotic/hypomelanotic lentigo maligna.

amelanotic melanoma dermoscopy lentigo maligna nonmelanocytic skin lesion reflectance confocal microscopy

Journal

The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545

Informations de publication

Date de publication:
13 Jan 2024
Historique:
revised: 21 11 2023
received: 20 06 2023
accepted: 27 11 2023
medline: 13 1 2024
pubmed: 13 1 2024
entrez: 13 1 2024
Statut: aheadofprint

Résumé

The dermoscopic diagnosis of amelanotic/hypomelanotic lentigo maligna/lentigo maligna melanoma (AHLM/LMM) may be very difficult in its early stages because of lack of pigment. Reflectance confocal microscopy (RCM) is an imaging technique that is especially helpful for the diagnosis of lentigo maligna. To determine the diagnostic performances of dermoscopy and RCM in the diagnosis of AHLM/LMMs we evaluated dermoscopic and RCM images of consecutive cases of histopathologically confirmed AHLM/LMMs, amelanotic/hypomelanotic basal cell carcinoma and squamous cell carcinoma (AHBCCs/AHSCCs), amelanotic/hypomelanotic benign lesions (AHBLs), and actinic keratoses (AKs) from five participating centers. Sensitivity, specificity, accuracy, predictive values, and level of diagnosis confidence were calculated for both diagnostic procedures. Both dermoscopy and RCM showed diagnostic performance >97% in the diagnosis of AHLM/LMMs versus AHBCC/AHSCCs and their combination slightly improved diagnostic performance, with accuracy increasing from 98.0% to 99.1%. Similarly, RCM in combination with dermoscopy showed a tiny increase in the diagnostic performance in the diagnosis of AHLM/LMMs versus AHBLs (accuracy increased from 87.2% to 88.8%) and versus AKs (accuracy increased from 91.4% to 93.4%). Although the increase in diagnostic performance due to RCM was modest, the combination of dermoscopy and RCM greatly increased the level of confidence; high confidence in the diagnosis of AHLM/LMMs versus AHBLs increased from 36.2% with dermoscopy alone to 76.6% with dermoscopy plus RMC. Based on our results, dermoscopy and RCM should be complementary to improve not only diagnostic accuracy but also the level of diagnostic certainty in the diagnosis of AHLM/LMMs.

Identifiants

pubmed: 38217366
doi: 10.1111/1346-8138.17075
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.

Références

Cliff S, Otter M, Holden CA. Amelanotic lentigo maligna melanoma of the face: a case report and review of the literature. Clin Exp Dermatol. 1997;22:177-179.
Abdulla FR, Kerns MJ, Mutasim DF. Amelanotic lentigo maligna: a report of three cases and review of the literature. J Am Acad Dermatol. 2010;62:857-860.
Giacomel J, Lallas A, Zalaudek I, Argenziano G. Dermoscopic “signature” pattern of pigmented and nonpigmented lentigo maligna. J Am Acad Dermatol. 2014;70:33-35.
Pralong P, Bathelier E, Dalle S, Poulalhon N, Debarbieux S, Thomas L. Dermoscopy of lentigo maligna melanoma: report of 125 cases. Br J Dermatol. 2012;167:280-287.
Borsari S, Pampena R, Lallas A, Kyrgidis A, Moscarella E, Benati E, et al. Clinical indications for use of reflectance confocal microscopy for skin cancer diagnosis. JAMA Dermatol. 2016;152:1093-1098.
Guitera P, Pellacani G, Crotty KA, Scolyer RA, Li LXL, Bassoli S, et al. The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face. J Invest Dermatol. 2010;130:2080-2091.
Pizzichetta MA, Polesel J, Perrot JL, Rubegni P, Fiorani D, Rizzo A, et al. Amelanotic/hypomelanotic lentigo maligna: Dermoscopic and confocal features predicting diagnosis. J Eur Acad Dermatol Venereol. 2022;37:303-310.
Lallas A, Argenziano G, Moscarella E, Longo C, Simonetti V, Zalaudek I. Diagnosis and management of facial pigmented macules. Clin Dermatol. 2014;32:94-100.
Shahriari N, Grant-Kels JM, Rabinovitz H, Oliviero M, Scope A. Reflectance confocal microscopy diagnostic criteria of common benign and malignant neoplasms, dermoscopic and histopathologic correlates of key confocal criteria, and diagnostic algorithms. J Am Acad Dermatol. 2021;84:17-31.
Longo C, Moscarella E, Argenziano G, Lallas A, Raucci M, Pellacani G, et al. Reflectance confocal microscopy in the diagnosis of solitary pink tumours:review of diagnostic clue. Br J Dermatol. 2015;173:31-41.
Lallas A, Lallas K, Tschandl P, Kittler H, Apalla Z, Longo C, et al. The dermoscopic inverse approach significantly improbe the accuracy of human readers for lentigo maligna diagnosis. J Am Acad Dermatol. 2021;84:381-389.
Mendes FBR, Braga JCT, Pinto CAL, De Macedo MP, Rabinovitz H, Rezze GG. Pigmented lesion on the face: which is the chance of being melanoma using reflectance confocal microscopy features? Arch Dermatol Res. 2022;314:563-571.
Pizzichetta MA, Canzonieri V, Rubegni P, Corneli P, Puglisi F, Zalaudek I, et al. Tips for difficult to diagnose hypomelanotic melanomas on reflectance confocal microscopy. J Dermatol. 2021;48:1067-1072.
Cinotti E, Labeille B, Debarbieux S, Carrera C, Lacarrubba F, Witkowski AM, et al. Dermoscopy vs reflectance confocal microscopy for the diagnosis of lentigo maligna. J Eur Acad Dermatol Venereol. 2018;32:1284-1291.
Cinotti E, Fiorani D, Labeille B, Gonzalez S, Debarbieux S, Agozzino M, et al. The integration of dermoscopy and reflectance confocal microscopy improves the diagnosis of lentigo maligna. J Eur Acad Dermatol Venereol. 2019;33:e372-e374.

Auteurs

Maria Antonietta Pizzichetta (MA)

Department of Dermatology, University of Trieste, Trieste, Italy.
Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano IRCCS, Istituto di ricovero e cura a carattere scientifico, Aviano, Italy.

Jerry Polesel (J)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy.

Jean Luc Perrot (JL)

Department of Dermatology, University Hospital of Saint Etienne, Saint-Etienne, France.

Pietro Rubegni (P)

Department of Medical, Surgical and Neurological Science, Dermatology Section, University of Siena, S. Maria alle Scotte Hospital, Siena, Italy.

Ignazio Stanganelli (I)

Department of Dermatology, University of Parma-Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCS, Meldola, Italy.
Skin Cancer Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy.

Serena Magi (S)

Skin Cancer Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy.

Laura Mazzoni (L)

Skin Cancer Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy.

Francesca Farnetani (F)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Giovanni Pellacani (G)

Department of Dermatology, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

Mattia Garutti (M)

Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano IRCCS, Istituto di ricovero e cura a carattere scientifico, Aviano, Italy.

Fabio Puglisi (F)

Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano IRCCS, Istituto di ricovero e cura a carattere scientifico, Aviano, Italy.
Department of Medicine, University of Udine, Udine, Italy.

Elisa Cinotti (E)

Department of Medical, Surgical and Neurological Science, Dermatology Section, University of Siena, S. Maria alle Scotte Hospital, Siena, Italy.

Classifications MeSH